-
Beida Pharmaceuticals is going to the Hong Kong Stock Exchange to list, and two more anti-cancer
Time of Update: 2021-03-04
cancer, ensartinib, in the second decade. this is a new powerful, highly selective new generation of APK inhibitors, by effectively inhibiting the activity of APK, to inhibit tumor growth. 2020, Nsatinib was approved for listing in China
-
Ningbo test water doctor title can go up and down
Time of Update: 2021-03-04
"The pay distribution will be tilted towards high-risk medical services, key positions, new technologies and the front lines of health care, fully reflecting high technology, high risk, high responsibility and high remuneration; Recently, the Ningbo
-
New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority
Time of Update: 2021-03-04
phase II clinical trial data show that Esbriet slowed the progression of the disease in UIDD patients at 24 weeks of treatment compared to a placebo.
-
Domestic wooden door "going out" government support is very important
Time of Update: 2021-03-04
China Coatings Network : In the era of economic globalization, as far as coatings industry is concerned, the Chinese market is certainly large, but the international market should also be involved. To this , the enterprises
-
(voxelotor), is under EU review and is on the market in the US!
Time of Update: 2021-03-03
maa sought full approval from the EMA for Oxbryta to treat hemolytic anemia in patients aged 12 years and older with sickle cell disease (SCD).
-
New drug for cystic fibrosis (CF)! Vertex triple therapy Trikafta has been given FDA priority review to expand the population (6-11 years old)!
Time of Update: 2021-03-03
therapy Trikafta (elexacaftor/tezacaftor/ivacaftor and the scope of use of cavtor) to include CFTR gene carrying at least one F508del mutation, or CFTR gene carrying a specific mutation and based on in vitro data to respond to Trikafta treatment of 6
-
New Alzheimer's (AD) drug! The review period of β protein antibody aducanumab was extended by 3 months by the FDA!
Time of Update: 2021-03-03
